top of page

About

Nu har bolaget nått upp till 100 miljoner i investerat kapital – och växlar upp genom att plocka in Digiexam-medgrundaren Nima Marefat som partner och COO.

Head quarters

Secondaries

Turnover

Secondaries

Number of employees:

Secondaries

Website

Secondaries

Documents & links

Global scaling through licensing of software as a service (SaaS) platform

Nu har bolaget nått upp till 100 miljoner i investerat kapital – och växlar upp genom att plocka in Digiexam-medgrundaren Nima Marefat som partner och COO.

“Private companies have huge potential upside. The challenge is that they are usually closed to investment. We created Tioex as a new way in.”
Mask group

Johan Hägglund

Founding Partner, CEO

Press

6 May 2022

One of Sweden’s biggest providers of digital healthcare.

6 May 2022

One of Sweden’s biggest providers of digital healthcare.

6 May 2022

One of Sweden’s biggest providers of digital healthcare.

Submit interest to invest

How much would you like

to invest?

Your details

Tioex is using a profit share model where investors first receives the invested capital back and then the profit is split 80% to investors and 20% to Tioex. Once the company goes public we will most likely hand out the shares to the investors. The potential profit will most likely be paid out in shares to Tioex.

You will invest together with a group of individuals through a holding company called Tioex Investment (unique number for each investment) AB, where we will all own the shares together with the sole purpose of investing in the target company. Tioex will handle all of the administration and paperwork until the target company gets sold or is doing an IPO. You can invest personally or through a holding company.

Please be sure to conduct your own research about the company and also seriously consider the risks and the implication of investing in a private unlisted company before you apply to invest.

Disclaimer:

Please notice that all investments on the Tioex platform are investments in the target companies by acquiring secondary shares (e.g. existing shares). The counterparts in these transactions are individual existings shareholders of the target companies that sell existing shares. The target company is not a counterpart in this process, except for handling transfer requests and making sure that the shareholder agreement of the company is followed. As a consequence, Tioex does not have access to any material provided by the company, such as investment memorandum or financial forecasts. Therefore the investments through Tioex are not to be seen as fundraising for the company.

Not live

bottom of page